VINTAFECT

What this means for you

This application is over — abandoned 27 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98800120

Mark type

Stylized text

Filed

14 Oct 2024

Abandoned

27 Oct 2025

Attorney of record

Julia M. Chester

Goods and services

• Class 040 — Treatment of materials: Manufacturing services for others in the field of biologics; manufacturing services for others in the field of transient transfection technology; biomanufacturing for others, namely, manufacturing of gene therapy products using biological organisms in the manufacturing process; cell therapy manufacturing for others; providing technical information in the field of pharmaceutical manufacturing; biomanufacturing of viral vectors and gene therapy vectors; biomanufacturing services of cell lines and cells
• Class 042 — Scientific and technological services: Product research and development in the fields of biology and medical sciences; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biologics; pharmaceutical drug and biologics delivery technology development services, namely, research and development in the area of pharmaceutical drug and biologics delivery systems in the nature of viral vectors; biological research and analysis; consulting services in the fields of research and development of biologics; scientific and technological services, namely, scientific research, analysis and testing in the field of biological vectors; scientific research services in the field of cell modification; pharmaceutical research services, namely, protein and cell line development and production; genetic engineering services utilizing a collection of genetic technologies for the rapid production of cell lines; scientific, laboratory and medical research in the field of cell line engineering; scientific laboratories performing cell line development; scientific research and development, namely, development of cell lines and proteins for others

Owner

• Vintabio, Inc., Philadelphia, PA, US

Prosecution history

• 10 Nov 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 10 Nov 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 24 Jul 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 24 Jul 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 24 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 24 Apr 2025 — NON-FINAL ACTION E-MAILED
• 24 Apr 2025 — NON-FINAL ACTION WRITTEN
• 16 Apr 2025 — ASSIGNED TO EXAMINER
• 15 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 14 Oct 2024 — NEW APPLICATION ENTERED